Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS; North American Imaging in Multiple Sclerosis Cooperative.

Neurology. 2019 Mar 12;92(11):519-533. doi: 10.1212/WNL.0000000000007099. Epub 2019 Feb 20. Review. Erratum in: Neurology. 2019 Jul 2;93(1):46.

PMID:
30787160
2.

MRI measures of neuroprotection and repair in multiple sclerosis.

Inglese M.

J Neurol Sci. 2011 Dec;311 Suppl 1:S16-23.

PMID:
22206761
3.

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative.

Nat Rev Neurol. 2016 Dec;12(12):714-722. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11. Review.

PMID:
27834394
4.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

PMID:
12869717
5.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

[No authors listed]

Neurology. 2019 Jul 2;93(1):46. doi: 10.1212/WNL.0000000000007525. No abstract available.

PMID:
31262994
6.

Sodium channel blockers for neuroprotection in multiple sclerosis.

Yang C, Hao Z, Zhang L, Zeng L, Wen J.

Cochrane Database Syst Rev. 2015 Oct 21;(10):CD010422. doi: 10.1002/14651858.CD010422.pub2. Review.

PMID:
26486929
7.

The NAIMS cooperative pilot project: Design, implementation and future directions.

Oh J, Bakshi R, Calabresi PA, Crainiceanu C, Henry RG, Nair G, Papinutto N, Constable RT, Reich DS, Pelletier D, Rooney W, Schwartz D, Tagge I, Shinohara RT, Simon JH, Sicotte NL; NAIMS Cooperative Steering Committee.

Mult Scler. 2018 Nov;24(13):1770-1772. doi: 10.1177/1352458517739990. Epub 2017 Nov 6.

PMID:
29106329
8.

Magnetic resonance monitoring of lesion evolution in multiple sclerosis.

Rovira A, Auger C, Alonso J.

Ther Adv Neurol Disord. 2013 Sep;6(5):298-310. doi: 10.1177/1756285613484079.

9.

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.

Barkhof F, Calabresi PA, Miller DH, Reingold SC.

Nat Rev Neurol. 2009 May;5(5):256-66. doi: 10.1038/nrneurol.2009.41. Review.

PMID:
19488083
10.

Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.

Martin AR, Aleksanderek I, Cohen-Adad J, Tarmohamed Z, Tetreault L, Smith N, Cadotte DW, Crawley A, Ginsberg H, Mikulis DJ, Fehlings MG.

Neuroimage Clin. 2015 Dec 4;10:192-238. doi: 10.1016/j.nicl.2015.11.019. eCollection 2016. Review.

11.

Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?

Zivadinov R.

Neurology. 2007 May 29;68(22 Suppl 3):S72-82; discussion S91-6. Review.

PMID:
17548573
12.

Insights from magnetic resonance imaging.

Filippi M, Charil A, Rovaris M, Absinta M, Rocca MA.

Handb Clin Neurol. 2014;122:115-49. doi: 10.1016/B978-0-444-52001-2.00006-6. Review.

PMID:
24507516
13.

Recent developments in imaging of multiple sclerosis.

Poloni G, Minagar A, Haacke EM, Zivadinov R.

Neurologist. 2011 Jul;17(4):185-204. doi: 10.1097/NRL.0b013e31821a2643. Review.

PMID:
21712664
14.

Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).

Foffi G, Pastore A, Piazza F, Temussi PA.

Phys Biol. 2013 Aug;10(4):040301. Epub 2013 Aug 2.

PMID:
23912807
15.

Imaging outcome measures for progressive multiple sclerosis trials.

Moccia M, de Stefano N, Barkhof F.

Mult Scler. 2017 Oct;23(12):1614-1626. doi: 10.1177/1352458517729456. Review. Erratum in: Mult Scler. 2018 Feb;24(2):NP32.

16.

Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.

Inglese M, Grossman RI, Filippi M.

J Neuroimaging. 2005;15(4 Suppl):22S-29S. Review.

PMID:
16385016
17.

Functional brain imaging: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 1.

18.

Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis.

Giacomini PS, Arnold DL.

Curr Opin Neurol. 2008 Jun;21(3):272-7. doi: 10.1097/WCO.0b013e328300525b. Review.

PMID:
18451709
19.

Advanced magnetic resonance imaging techniques to better understand multiple sclerosis.

Zaaraoui W, Audoin B, Pelletier J, Cozzone PJ, Ranjeva JP.

Biophys Rev. 2010 May;2(2):83-90. doi: 10.1007/s12551-010-0031-6. Epub 2010 Apr 2.

20.

Current and new directions in MRI in multiple sclerosis.

Klawiter EC.

Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):1058-73. doi: 10.1212/01.CON.0000433283.00221.37. Review.

Supplemental Content

Support Center